| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 4 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Canada | 2 | |
| #5 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Medical technology | |
| #2 | Biotechnology | |
| #3 | Pharmaceuticals | |
| #4 | Measurement | |
| #5 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Measuring microorganism processes | |
| #3 | Implantable devices | |
| #4 | Electrotherapy | |
| #5 | Analysing materials | |
| #6 | Microorganisms | |
| #7 | Enzymes | |
| #8 | Peptides | |
| #9 | Diagnosis and surgery | |
| #10 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Repine John E | 10 |
| #2 | Mccord Joe M | 3 |
| #3 | Gao Bifeng | 3 |
| #4 | Flores Sonia C | 3 |
| #5 | Leff Jonathan A | 3 |
| #6 | Leff Joanathan A | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO02100293A2 | A diagnostic and prognostic method for evaluating ocular inflammation and oxidative stress and the treatment of the same | |
| EP1119352A1 | A method for the treatment of ocular oxidative stress | |
| US6190658B1 | Genetically modified manganese superoxide dismutase for treating oxidative damage | |
| EP0689674A1 | Serum antioxidants as predictors of adult respiratory distress syndrome |